Document Detail


Metabolomics in premature labor: a novel approach to identify patients at risk for preterm delivery.
MedLine Citation:
PMID:  20504069     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
OBJECTIVE: Biomarkers for preterm labor (PTL) and delivery can be discovered through the analysis of the transcriptome (transcriptomics) and protein composition (proteomics). Characterization of the global changes in low-molecular weight compounds which constitute the 'metabolic network' of cells (metabolome) is now possible by using a 'metabolomics' approach. Metabolomic profiling has special advantages over transcriptomics and proteomics since the metabolic network is downstream from gene expression and protein synthesis, and thus more closely reflects cell activity at a functional level. This study was conducted to determine if metabolomic profiling of the amniotic fluid can identify women with spontaneous PTL at risk for preterm delivery, regardless of the presence or absence of intraamniotic infection/inflammation (IAI).
STUDY DESIGN: Two retrospective cross-sectional studies were conducted, including three groups of pregnant women with spontaneous PTL and intact membranes: (1) PTL who delivered at term; (2) PTL without IAI who delivered preterm; and (3) PTL with IAI who delivered preterm. The first was an exploratory study that included 16, 19, and 20 patients in groups 1, 2, and 3, respectively. The second study included 40, 33, and 40 patients in groups 1, 2, and 3, respectively. Amniotic fluid metabolic profiling was performed by combining chemical separation (with gas and liquid chromatography) and mass spectrometry. Compounds were identified using authentic standards. The data were analyzed using discriminant analysis for the first study and Random Forest for the second.
RESULTS: (1) In the first study, metabolomic profiling of the amniotic fluid was able to identify patients as belonging to the correct clinical group with an overall 96.3% (53/55) accuracy; 15 of 16 patients with PTL who delivered at term were correctly classified; all patients with PTL without IAI who delivered preterm neonates were correctly identified as such (19/19), while 19/20 patients with PTL and IAI were correctly classified. (2) In the second study, metabolomic profiling was able to identify patients as belonging to the correct clinical group with an accuracy of 88.5% (100/113); 39 of 40 patients with PTL who delivered at term were correctly classified; 29 of 33 patients with PTL without IAI who delivered preterm neonates were correctly classified. Among patients with PTL and IAI, 32/40 were correctly classified. The metabolites responsible for the classification of patients in different clinical groups were identified. A preliminary draft of the human amniotic fluid metabolome was generated and found to contain products of the intermediate metabolism of mammalian cells and xenobiotic compounds (e.g. bacterial products and Salicylamide).
CONCLUSION: Among patients with spontaneous PTL with intact membranes, metabolic profiling of the amniotic fluid can be used to assess the risk of preterm delivery in the presence or absence of infection/inflammation.
Authors:
Roberto Romero; Shali Mazaki-Tovi; Edi Vaisbuch; Juan Pedro Kusanovic; Tinnakorn Chaiworapongsa; Ricardo Gomez; Jyh Kae Nien; Bo Hyun Yoon; Moshe Mazor; Jingqin Luo; David Banks; John Ryals; Chris Beecher
Related Documents :
21792729 - Mibg scintigraphy in differential diagnosis of parkinsonism: a meta-analysis.
19301289 - The impact of aspirin resistance on the long-term cardiovascular mortality in patients ...
14511999 - Fibrinogen predicts mortality in high risk patients with peripheral artery disease.
17087609 - Post-hoc analysis on the cd14 c(-260)t promoter polymorphism and coronary heart disease.
19298569 - Heart rate turbulence as a predictor of cardiac mortality and arrhythmic events in pati...
20098039 - The prevalence of aspirin resistance in patients with metabolic syndrome.
7482439 - Decreased fibrinolytic stimulation by a short-term venous occlusion test in patients wi...
15744509 - Transtympanic corticoid therapy for acute profound hearing loss.
11773549 - Current treatment of juvenile rheumatoid arthritis.
Publication Detail:
Type:  Journal Article; Research Support, N.I.H., Intramural     Date:  2010-05-26
Journal Detail:
Title:  The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians     Volume:  23     ISSN:  1476-4954     ISO Abbreviation:  J. Matern. Fetal. Neonatal. Med.     Publication Date:  2010 Dec 
Date Detail:
Created Date:  2010-11-11     Completed Date:  2011-02-17     Revised Date:  2013-03-28    
Medline Journal Info:
Nlm Unique ID:  101136916     Medline TA:  J Matern Fetal Neonatal Med     Country:  England    
Other Details:
Languages:  eng     Pagination:  1344-59     Citation Subset:  IM    
Affiliation:
Perinatology Research Branch, NICHD/NIH/DHHS, Bethesda, Maryland, USA. prbchiefstaff@med.wayne.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adolescent
Adult
Amniocentesis
Amniotic Fluid / chemistry,  microbiology
Chorioamnionitis / diagnosis
Cross-Sectional Studies
Female
Fourier Analysis
Gas Chromatography-Mass Spectrometry
Gestational Age
Humans
Mass Spectrometry
Metabolomics*
Obstetric Labor, Premature* / classification
Pregnancy
Premature Birth / diagnosis*
Retrospective Studies
Risk Factors
Grant Support
ID/Acronym/Agency:
ZIA HD002401-17/HD/NICHD NIH HHS
Comments/Corrections
Comment In:
J Matern Fetal Neonatal Med. 2011 Dec;24(12):1504; author reply 1504-5   [PMID:  21231835 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Detection of Ureaplasma urealyticum and Ureaplasma parvum in amniotic fluid: association with pregna...
Next Document:  Management of subsequent pregnancy after antepartum stillbirth. A review.